How to make regenerative medicine happen
Cell therapies hold the promise of more effective treatments for a range of diseases, but they face a long and expensive route to market. The key is to reduce risk and attract investors, says Keith Thompson, head of the UK Cell Therapy Catapult
Science|Business Innovation Board AISBL Annual Report 2012-2013
Could it help European universities innovate?
Perceptions of ACES finalists about the process of science entrepreneurship